Everest Medicines appointed Wu Yifang, ex-chairman of Fosun Pharma and ex-president of Fosun International, as the New York-based biopharma firm's chairman, succeeding Fu Wei. Wu was also named the executive operating partner of Everest's shareholder CBC Group yesterday.